Company Filing History:
Years Active: 2003-2006
Title: Innovations by Matthew S. Cowlen
Introduction
Matthew S. Cowlen is an accomplished inventor based in Chapel Hill, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the area of joint lubrication and gastrointestinal health. With a total of two patents to his name, Cowlen's work focuses on innovative methods to improve health outcomes for patients.
Latest Patents
Cowlen's latest patents include a method for joint lubrication using P2Y purinergic receptor agonists. This invention aims to alter the amount or composition of synovial fluids secreted from joints, providing relief for individuals suffering from conditions like osteoarthritis. The pharmaceutical composition involves administering a P2Y purinergic receptor agonist to stimulate the secretion of synovial fluid and enhance joint lubrication.
Another notable patent addresses gastrointestinal tract diseases through the use of purinergic receptor agonists. This invention regulates water and mucin secretions and fluid transport in the gastrointestinal tract. It provides a method for treating gastrointestinal diseases by correcting disorders of fluid secretion or absorption, thereby improving patient health.
Career Highlights
Matthew S. Cowlen is currently associated with Inspire Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His work has the potential to significantly impact the treatment of joint and gastrointestinal disorders, showcasing his dedication to improving patient care.
Collaborations
Cowlen has collaborated with notable colleagues such as Benjamin R. Yerxa and Janet L. Rideout. These partnerships have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Matthew S. Cowlen is a prominent inventor whose work in joint lubrication and gastrointestinal health demonstrates his commitment to advancing medical science. His innovative patents reflect a deep understanding of pharmaceutical applications that can enhance the quality of life for many patients.